| Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers E Olkhov‐Mitsel, B Bapat Cancer medicine 1 (2), 237-260, 2012 | 153 | 2012 |
| International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome A Hodgson, E Olkhov-Mitsel, BE Howitt, MR Nucci, C Parra-Herran Journal of clinical pathology 72 (5), 347-353, 2019 | 69 | 2019 |
| Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids E Olkhov-Mitsel, D Zdravic, K Kron, T van der Kwast, N Fleshner, B Bapat Scientific reports 4 (1), 1-8, 2014 | 65 | 2014 |
| Urinary DNA methylation biomarkers for noninvasive prediction of aggressive disease in patients with prostate cancer on active surveillance F Zhao, E Olkhov-Mitsel, T van der Kwast, J Sykes, D Zdravic, ... The Journal of urology 197 (2), 335-341, 2017 | 61 | 2017 |
| Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer E Olkhov-Mitsel, T Van der Kwast, K Kron, H Ozcelik, L Briollais, ... Epigenetics 7 (9), 1037-1045, 2012 | 55 | 2012 |
| Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there MD Pasic, E Olkhov, B Bapat, GM Yousef Biological chemistry 393 (5), 319-330, 2012 | 48 | 2012 |
| p53, mismatch repair protein, and POLE abnormalities in ovarian clear cell carcinoma: an outcome-based clinicopathologic analysis C Parra-Herran, D Bassiouny, J Lerner-Ellis, E Olkhov-Mitsel, N Ismiil, ... The American journal of surgical pathology 43 (12), 1591-1599, 2019 | 43 | 2019 |
| A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer F Zhao, E Olkhov-Mitsel, S Kamdar, R Jeyapala, J Garcia, R Hurst, ... Clinical epigenetics 10, 1-12, 2018 | 42 | 2018 |
| Temporal stability and prognostic biomarker potential of the prostate cancer urine miRNA transcriptome J Jeon, E Olkhov-Mitsel, H Xie, CQ Yao, F Zhao, S Jahangiri, C Cuizon, ... JNCI: Journal of the National Cancer Institute 112 (3), 247-255, 2020 | 40 | 2020 |
| Assessment of serum microRNA biomarkers to predict reclassification of prostate cancer in patients on active surveillance RSC Liu, E Olkhov-Mitsel, R Jeyapala, F Zhao, K Commisso, L Klotz, ... The Journal of urology 199 (6), 1475-1481, 2018 | 39 | 2018 |
| Measuring kinetic isotope effects in enzyme reactions using time-resolved electrospray mass spectrometry P Liuni, E Olkhov-Mitsel, A Orellana, DJ Wilson Analytical chemistry 85 (7), 3758-3764, 2013 | 36 | 2013 |
| Epigenome-wide DNA methylation profiling identifies differential methylation biomarkers in high-grade bladder cancer E Olkhov-Mitsel, AJ Savio, KJ Kron, VV Pethe, T Hermanns, NE Fleshner, ... Translational oncology 10 (2), 168-177, 2017 | 34 | 2017 |
| Combining urinary DNA methylation and cell-free microRNA biomarkers for improved monitoring of prostate cancer patients on active surveillance F Zhao, D Vesprini, RSC Liu, E Olkhov-Mitsel, LH Klotz, A Loblaw, SK Liu, ... Urologic Oncology: Seminars and Original Investigations 37 (5), 297. e9-297. e17, 2019 | 29 | 2019 |
| CTNNB1 mutations and aberrant β-catenin expression in ovarian endometrioid carcinoma: correlation with patient outcome RE Zyla, E Olkhov-Mitsel, Y Amemiya, D Bassiouny, A Seth, B Djordjevic, ... The American Journal of Surgical Pathology 45 (1), 68-76, 2021 | 23 | 2021 |
| Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors E Olkhov‑Mitsel, F Siadat, K Kron, L Liu, AJ Savio, J Trachtenberg, ... Oncology letters 14 (1), 390-396, 2017 | 22 | 2017 |
| FIGO versus Silverberg grading systems in ovarian endometrioid carcinoma: a comparative prognostic analysis C Parra-Herran, D Bassiouny, D Vicus, E Olkhov-Mitsel, M Cesari, N Ismiil, ... The American Journal of Surgical Pathology 43 (2), 161-167, 2019 | 20 | 2019 |
| A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade T Hermanns, AJ Savio, E Olkhov-Mitsel, A Mari, MS Wettstein, K Saba, ... Urologic Oncology: Seminars and Original Investigations 38 (6), 603. e1-603. e7, 2020 | 17 | 2020 |
| Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer NMA White-Al Habeeb, LT Ho, E Olkhov-Mitsel, K Kron, V Pethe, ... Oncotarget 5 (17), 7858, 2014 | 17 | 2014 |
| Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer L Briollais, H Ozcelik, J Xu, M Kwiatkowski, E Lalonde, DH Sendorek, ... JNCI: Journal of the National Cancer Institute 109 (4), djw258, 2017 | 16 | 2017 |
| An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patients R Jeyapala, S Kamdar, E Olkhov-Mitsel, AJ Savio, F Zhao, C Cuizon, ... Urologic Oncology: Seminars and Original Investigations 38 (2), 39. e1-39. e9, 2020 | 14 | 2020 |
